JP2023500360A5 - - Google Patents

Info

Publication number
JP2023500360A5
JP2023500360A5 JP2022526378A JP2022526378A JP2023500360A5 JP 2023500360 A5 JP2023500360 A5 JP 2023500360A5 JP 2022526378 A JP2022526378 A JP 2022526378A JP 2022526378 A JP2022526378 A JP 2022526378A JP 2023500360 A5 JP2023500360 A5 JP 2023500360A5
Authority
JP
Japan
Prior art keywords
composition according
composition
brain
item
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022526378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023500360A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/058905 external-priority patent/WO2021092026A1/en
Publication of JP2023500360A publication Critical patent/JP2023500360A/ja
Publication of JP2023500360A5 publication Critical patent/JP2023500360A5/ja
Priority to JP2025076413A priority Critical patent/JP2025107344A/ja
Pending legal-status Critical Current

Links

JP2022526378A 2019-11-04 2020-11-04 N-アセチルシステインの鼻腔内投与のための用量、製剤、およびデバイスを較正および選択するための磁気共鳴分光法の使用 Pending JP2023500360A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025076413A JP2025107344A (ja) 2019-11-04 2025-05-01 N-アセチルシステインの鼻腔内投与のための用量、製剤、およびデバイスを較正および選択するための磁気共鳴分光法の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962930473P 2019-11-04 2019-11-04
US62/930,473 2019-11-04
PCT/US2020/058905 WO2021092026A1 (en) 2019-11-04 2020-11-04 Use of magnetic resonance spectroscopy to calibrate and select doses, formulations, and devices for intra-nasal administration of n-acetylcysteine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025076413A Division JP2025107344A (ja) 2019-11-04 2025-05-01 N-アセチルシステインの鼻腔内投与のための用量、製剤、およびデバイスを較正および選択するための磁気共鳴分光法の使用

Publications (2)

Publication Number Publication Date
JP2023500360A JP2023500360A (ja) 2023-01-05
JP2023500360A5 true JP2023500360A5 (cg-RX-API-DMAC7.html) 2023-11-28

Family

ID=75688247

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022526378A Pending JP2023500360A (ja) 2019-11-04 2020-11-04 N-アセチルシステインの鼻腔内投与のための用量、製剤、およびデバイスを較正および選択するための磁気共鳴分光法の使用
JP2025076413A Pending JP2025107344A (ja) 2019-11-04 2025-05-01 N-アセチルシステインの鼻腔内投与のための用量、製剤、およびデバイスを較正および選択するための磁気共鳴分光法の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025076413A Pending JP2025107344A (ja) 2019-11-04 2025-05-01 N-アセチルシステインの鼻腔内投与のための用量、製剤、およびデバイスを較正および選択するための磁気共鳴分光法の使用

Country Status (7)

Country Link
US (2) US20210128509A1 (cg-RX-API-DMAC7.html)
EP (1) EP4054410A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023500360A (cg-RX-API-DMAC7.html)
CN (1) CN115515484A (cg-RX-API-DMAC7.html)
AU (1) AU2020380291A1 (cg-RX-API-DMAC7.html)
CA (1) CA3160283A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021092026A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3618824A4 (en) * 2017-05-02 2021-06-23 Neuronasal, LLC USE OF N-ACETYLCYSTONE FOR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
US12594254B2 (en) * 2022-02-07 2026-04-07 Neuronasal, Inc. Intranasal administration of n-acetylcysteine and uses thereof
WO2023192691A2 (en) * 2022-04-01 2023-10-05 Wake Forest University Health Sciences Methods and formulations for intranasal delivery of insulin in the treatment of diabetic eye disease
US20250371713A1 (en) * 2024-05-28 2025-12-04 Debra Strick Rivera Mapping glutathione deficiency and/or dysfunction of mitochondria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100099762A1 (en) * 2006-10-23 2010-04-22 The Mental Health Research Institute Of Victoria Combination therapy
WO2013163545A1 (en) * 2012-04-26 2013-10-31 Sentient Lifesciences, Inc. Use of n-acetylcysteine amide in the treatment of disease and injury
US20160058726A1 (en) * 2013-04-16 2016-03-03 The Children's Hospital Of Philadelphia Compositions and methods for the treatment of brain injury
EP3618824A4 (en) * 2017-05-02 2021-06-23 Neuronasal, LLC USE OF N-ACETYLCYSTONE FOR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
EP3700525A4 (en) * 2017-10-27 2021-08-25 Beyond Barriers Therapeutics, Inc. IMPROVED PROVISION OF ANTIOXIDANTS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES WITH OXIDATIVE STRESS
CA3165422A1 (en) * 2019-12-18 2021-06-24 Neuronasal, Inc. Methods of treating brain disorders

Similar Documents

Publication Publication Date Title
JP2023518635A5 (cg-RX-API-DMAC7.html)
JP2023171776A (ja) 成人における焦点てんかんの処置のための合成経皮的カンナビジオール
Fenelon et al. Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study
Imran et al. Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review
JP2021152060A (ja) アカンプロセートおよびd−サイクロセリンを使用する組み合わせ療法
JP2020534270A5 (cg-RX-API-DMAC7.html)
JP2023535744A5 (cg-RX-API-DMAC7.html)
CN105327349A (zh) Nmda受体拮抗剂的医药用途及其药物组合物
JP2020075938A (ja) 神経精神系障害の治療のための組成物および方法
JP2024517085A5 (cg-RX-API-DMAC7.html)
US6384083B1 (en) Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals
JP2002511875A (ja) 勃起機能障害治療用のヨヒンビンおよびアルギニン含有薬
Park et al. Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat
CN113116877A (zh) L-4-氯犬尿氨酸的剂型和治疗用途
JP2021530568A5 (cg-RX-API-DMAC7.html)
MX2007006825A (es) Agente preventivo o terapeutico para trastorno del sueno.
JP2023520703A5 (cg-RX-API-DMAC7.html)
US20250288548A1 (en) Intranasal baclofen
JP2024502466A5 (cg-RX-API-DMAC7.html)
KR20220066985A (ko) 퇴행성 신경질환의 치료 방법
RU2318516C2 (ru) Способ лечения эректильной дисфункции у мужчин
JP2024518426A5 (cg-RX-API-DMAC7.html)
JP2023538859A5 (cg-RX-API-DMAC7.html)
RU2401123C2 (ru) Способ лечения псориаза у детей
CN110234335B (zh) 治疗女性性功能障碍的药物组合物和方法